High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
about
Insights into human immunodeficiency virus-hepatitis B virus co-infection in IndiaConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesComparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionHigh prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, ChinaOutcomes of antiretroviral therapy in Vietnam: results from a national evaluationThe impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People's Republic of China: a population-based survey and testing studySeroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic reviewIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programmeGeographic integration of hepatitis C virus: A global threat.Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South IndiaOccult Hepatitis B Virus Infection among HIV Positive Patients in NigeriaPrevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.The impact of HIV and high-risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV preventionThe profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions.Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groupsLow incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, IndiaThe relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, IndiaHepatitis C in HIV-infected individuals: cure and control, right now.Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India.High HIV burden among people who inject drugs in 15 Indian cities.The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India.Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India.HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in IndiaGender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India.Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, IndiaFactors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India.Mortality among injection drug users in Chennai, India (2005-2008).Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India.Effect of peer-led outreach activities on injecting risk behavior among male drug users in Haryana, IndiaEmergence of cocaine and methamphetamine injection among HIV-positive injection drug users in northern and western India.The availability, diversion and injection of pharmaceutical opioids in South Asia.High uptake of HIV testing in a cohort of male injection drug users in Delhi, India: prevalence and correlates of HIV infection.
P2860
Q26797826-4E674EA0-3BF6-44D0-9500-D789CAC4B094Q27010612-6B791138-71B1-443F-9038-1CC24C114B46Q27488883-AB5047EF-0127-4836-87D3-71270BA6090CQ28476802-0C6EFECB-7D10-4342-B599-1D285DFB7D5CQ28482312-3F2A2462-F015-4013-8308-C02A28C54A31Q28486180-FE7921DB-632A-4420-9066-33A98D0E03CCQ28540272-E38B678A-091F-48CA-B7B7-36D0E8C82ACEQ30241549-EF01F82B-7E86-407E-9ECD-7EC02E595B4AQ30355190-7B4B73A7-327E-442B-ADD9-56DA449EC707Q30395529-7BB40C01-B268-4FF5-A4B9-39AA022785A0Q30395543-EB1F13F0-F442-43A0-B4F9-3B7324746447Q33596934-F3E25F87-440B-4D5E-9CA0-DAAE55FD2597Q33607322-7300F825-FB6A-4DCA-8EB8-AD5C8B645D49Q33754364-CECFD956-083F-464A-B83C-1CC80D2036A0Q33935693-177487B2-E423-4D8D-8CBA-9AF3A064A163Q34075539-B29E66FC-D8F4-4490-A4F7-E82AD4229817Q34245650-28409F27-102E-4714-8E7D-6486E7373049Q34410211-C891C182-4DFB-4918-88E7-9BBA5980E3F4Q34514182-311B3393-1B83-448B-AAA8-D9C64ADE3BDCQ35008591-F14A8671-ACFB-4E96-A035-CCB4E005E169Q35037944-AA29526C-1C07-4F96-9797-3D897203067BQ35047562-2A210E6C-3C57-4B00-88DF-BA63FECE117CQ35102720-08AEB423-4311-480D-B837-D514EFB81EE6Q35137055-4A10148E-5DBE-4CFD-91D4-70F084BC3D10Q35203268-6E33AA66-C227-4E1A-AA43-657FC5405C24Q35235877-596F6E5E-1D70-4FEA-8C4E-C6CD109C946CQ35569047-9BBFF240-3449-441E-881F-3BD94C48DA13Q35724789-D458F644-11A0-4F38-BC45-F96E5045E753Q35904838-E2401834-08AF-47A6-BA8D-CE3EF28A79BCQ36192090-80A771CA-EEE1-4305-A2F7-A93DD1EA6AC8Q36252631-A100D450-32E2-4A0D-B286-B65F3C9F1ABAQ36523925-0CE0F052-2D4C-4A51-A1A7-58DC0F969D6EQ37024408-B2B115FF-04AA-479F-9AA7-501078701071Q37089469-1451A373-A347-4E26-8234-A0A35C97F19AQ37230008-8D4C1E79-F3A1-4695-8502-A8B0C173547DQ37305630-1CBBDEC1-88B4-4278-8715-3E4D228C12D7Q37580634-0C9D504B-5C97-4BC3-A8DB-858DB0107983Q37634976-6EA45386-A4C5-4395-8A6C-8EDD11BFCB43Q37872348-E9AC5EBE-C9C7-4CD8-99F9-57FF57D3055EQ38087819-ED07E977-60B8-4A3D-8705-1EAEA764C11B
P2860
High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@en
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@nl
type
label
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@en
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@nl
prefLabel
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@en
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@nl
P2093
P2860
P50
P921
P1476
High prevalence of HIV, HIV/he ...... i, India: a cause for concern.
@en
P2093
Aylur K Srikrishnan
Conjeevaram K Vasudevan
Easter Thamburaj
Kailapuri G Murugavel
M Suresh Kumar
Santhanam Anand
Shruti H Mehta
Sunil S Solomon
P2860
P304
P356
10.1097/QAI.0B013E3181831E85
P407
P577
2008-11-01T00:00:00Z